Search Results

You searched for : NASDAQ  

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology....
Apr 17

Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic Production

Aurangabad, India site is the country’s first pharmaceutical facility, and first in Viatris’ network, to meet new British Standards Institution (BSI) Kitemark certification ...
Feb 20

Shiprocket collaborated with Truecaller to empower sellers with reliable and seamless e-commerce transactions

Shiprocket has done a strategic partnership with Truecaller, the globally renowned communication platform, to cater to the ever-evolving landscape of mobile commerce. This collaboration ...
Jan 17

ArchiMed Group plans to acquire Natus Medical for $1.2 billion

Natus Medical has achieved a deal worth $1.2 billion offered by France-based ArchiMed Group. The deal would remove Natus Medical from public trading, ...
Apr 21

Novo Nordisk announces completion of Dicerna Pharmaceuticals acquisition

Latest pharma news update...
Dec 30

Sanofi completes acquisition of Kadmon

Latest pharma news updates...
Nov 12

Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics

Latest pharma news update...
Sep 20

Adicet Bio collaborates with Twist Bioscience to accelerate discovery of Gamma Delta T Cell Cancer Therapeutics

Latest pharma news update...
Sep 16

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

Latest pharma Update...
Sep 06

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology

Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ...
Jun 22

Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA influenza vaccine

Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise...
Jun 22

Pharvaris Announces FDA Acceptance of IND Application for Prophylactic Treatment of HAE Using PHVS416

Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. ...
Apr 23

Pfizer and Biontech publish results of study showing COVID-19 vaccine elicits antibodies that neutralize Pseudovirus bearing the SARS-COV-2 U.K

While the pseudovirus system used is a surrogate for authentic SARS-CoV-2, previous studies have shown excellent concordance between pseudotype neutralization and SARS-CoV-...
Jan 21

Pfizer invests $120 million in biotechnology innovation through the Pfizer breakthrough growth initiative

Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the ...
Jan 13

Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine

Serum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/...
Dec 24

ObsEva Announces Additional Phase 3 PRIMROSE 1 and 2 Study Results Confirming Sustained Efficacy and Continued Safety of linzagolix in the Treatment of Uterine Fibroids

ObsEva, today announced topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy ...
Dec 10

Arbutus Announces Presentation of Phase 1a/1b Clinical Trial Results for AB-729 in Chronic Hepatitis B Subjects at The Liver Meeting Digital Experienceâ„¢, The American Association for the Study of Liver Diseases Meeting

Arbutus Biopharma Corporation a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection as well ...
Nov 16

Akers Biosciences and MyMD Pharmaceuticals sign definitive merger agreement

Through this merger, the company will be able to deliver novel, multi-indication platform drugs designed to extend healthy lifespan and treat the source of ...
Nov 13

PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine

PDS Biotech and Farmacore today announced Updates on its co-development program for a Versamune®-based vaccine aimed at preventing COVID-19 infection....
Nov 11

CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport

Centogene, announced today the opening of its walk-in COVID-19 testing facility at the newly opened Berlin Brandenburg Airport (BER)....
Nov 05

Align Technology to Award Research Programs Advancing Orthodontic and Dental Patient Care

Align Technology, today announced the opening of its 2021 Research Award Program to support clinical and scientific dental research in universities across the globe....
Nov 03

ViralClear halts its Phase 2 Hospitalized COVID-19 Trial

ViralClear Pharmaceuticals, Inc. announced the halting of its signal finding Phase 2 hospitalized Covid-19 trial....
Oct 27

New Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers

Researchers will present new data supporting the Xoft System for the treatment of early-stage breast cancer and gynecological cancers....
Oct 24

Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer

Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer...
Oct 24

Nevakar Announces FDA Approval for Ephedrine Sulfate Injection as Ready-to-Use Vials

The U.S. Food and Drug Administration (FDA) to market Ephedrine Sulfate Injection in a ready-to-use 50mg/10 ml single use vial presentation....
Oct 22

25 Matching result(s) found!

-Advertisements-




Trending Now

Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024